Reprogram the Genome of M13 Phage for Vaccination and Immunotherapy Applications
Invention type: Technology
/
Case number: #25169
Researchers
Departments: David H Koch Institute for Integrative Cancer Res, Department of Biological Engineering
Technology Areas: Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Vaccines
Impact Areas: Healthy Living
-
reprogramming the genome of phage for vaccination and immunotherapy applications
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.